Most of the biotechnology stocks in Hong Kong stocks strengthened, Kangsinuo Biological (06185.HK) rose more than 10%, BeiGene (06160.HK) rose more than 6%, Nuocheng Jianhua (09969.HK) rose more than 4%, Tiger Pharmaceutical (03347.HK) rose more than 3%.
港股生物技术股多数走强,康希诺生物(06185.HK)涨超10%,百济神州(06160.HK)涨超6%,诺诚健华(09969.HK)涨超4%,泰格医药(03347.HK)涨超3%。
Hong Kong stocks CXO concept stocks initially pulled up, WuXi Bio (02269.HK) rose more than 9%, Zhaoyan New Drug (06127.HK), WuXi PharmaTech (02359.HK) rose more than 4%, Tiger Pharmaceutical (03347.HK) rose more than 3%.
港股CXO概念股盘初拉升,药明生物(02269.HK)涨超9%,昭衍新药(06127.HK)、药明康德(02359.HK)涨超4%,泰格医药(03347.HK)涨超3%。
Hong Kong pharmaceutical stocks strengthened in the afternoon, WuXi PharmaTech (02359.HK) rose more than 5%, WuXi Bio (02269.HK) rose more than 4%, Tiger Pharmaceutical (03347.HK), Zhaoyan New Drug (06127.HK) and so on.
港股医药股午后走强,药明康德(02359.HK)拉升涨超5%,药明生物(02269.HK)涨超4%,泰格医药(03347.HK)、昭衍新药(06127.HK)等跟涨。